Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Cash-Strapped Alder Biopharma Secures $160 Million in Stock Sale to Continue Operations July 13, 2017 Elekta Radiosurgery Solutions Highlighted At May 25, 2017 Novartis' Sandoz Jobs on the Chopping Block February 8, 2018
Cash-Strapped Alder Biopharma Secures $160 Million in Stock Sale to Continue Operations July 13, 2017
